## **Core Concept**
The Lepromin test, also known as the Mitsuda reaction, is a skin test used to assess the immune response against *Mycobacterium leprae*, the causative agent of leprosy. It measures the cell-mediated immunity to lepromin, a preparation of inactivated *M. leprae*. The test is primarily used to classify leprosy and predict the prognosis.

## **Why the Correct Answer is Right**
The correct answer, ** tuberculoid leprosy**, is associated with a positive Lepromin test because patients with this form of leprosy have a strong cell-mediated immune response against *M. leprae*. This robust immune response limits the disease to a few skin lesions and peripheral nerves. The positive test indicates that the individual's immune system can mount an effective response against the antigen, correlating with a better prognosis.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Lepromatous leprosy is characterized by a poor cell-mediated immune response, which results in a negative Lepromin test. This form of leprosy is associated with widespread skin lesions and nerve involvement.
* **Option B:** This option is not applicable as it is not provided.
* **Option D:** Borderline leprosy may have a variable immune response, but it is less likely to have a strongly positive Lepromin test compared to tuberculoid leprosy. The immune response in borderline leprosy is not as robust as in tuberculoid leprosy.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that a positive Lepromin test is indicative of tuberculoid leprosy and suggests a good prognosis. Conversely, a negative test is often seen in lepromatous leprosy, indicating a poor immune response and a worse prognosis. This test is crucial for classifying leprosy and guiding treatment.

## **Correct Answer:** . Tuberculoid Leprosy